Glaucoma Drainage Devices Market Size is valued at 808.4 Million in 2024 and is predicted to reach 2,130.5 Million by the year 2034 at an 10.3% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Glaucoma drainage devices are used to drain and divert humor that is caused in the glaucoma condition which could lead to serious damage to the eye if not treated properly. Ill-treated glaucoma could also lead to blindness. The increasing prevalence of lifestyle disorders and the rising geriatric population are the prime factors driving the glaucoma drainage devices market potential over the forecast period. Increasing incidence of diabetes is also expected to further increase glaucoma and this will eventually favor the glaucoma drainage devices market potential over the coming years.
Technological innovations in glaucoma treatment and rising healthcare spending potential across the world are also expected to boost glaucoma drainage devices’ market growth across the forecast period. Hypertension is also responsible for the increasing incidence of glaucoma and could further propel the demand for glaucoma drainage devices through 2031.
The emergence of the COVID-19 pandemic in 2020 led to a downward trend in the global glaucoma drainage devices market owing to a heightened focus on coronavirus infections to control the pandemic situation. The glaucoma drainage devices market is anticipated to rise at a steady pace over the forecast period as the restrictions are lifted and the world returns to normal. However, complications related to glaucoma procedures are expected to have a hampering effect on the global glaucoma drainage devices demand through 2031.
The glaucoma drainage devices market is segmented on the basis of product and end-users. Based on the product, the market is segmented as valved implants and non-valved implants. By end-users, the market is segmented into hospitals, ophthalmic clinics, and other end-users.
Valved implants are anticipated to see high demand over the forecast period and are anticipated to witness growth faster than the non-valved implants segment. Increasing preference for valved implants and rising recommendations for the same from healthcare professionals are expected to drive the growth of the segment over the forecast period.
The hospitals segment is anticipated to account for a major market share over the forecast period owing to a rising number of glaucoma surgeries being performed. The presence of key glaucoma treatments and the availability of novel technologies are factors that could drive demand for glaucoma drainage devices in hospitals.
The North America glaucoma drainage devices market is anticipated to emerge as the most lucrative one in the global glaucoma drainage devices industry landscape owing to the rising prevalence of glaucoma in the growing geriatric population. The increasing prevalence of diabetes is also a factor that propels glaucoma drainage devices demand in this region. Favorable reimbursement policies, developed healthcare infrastructure, high spending potential, and the presence of key healthcare providers are other factors that positively influence the glaucoma drainage devices market growth through 2031. The United States and Canada are projected to emerge as the most lucrative markets in the North America region over the years to come.
| Report Attribute | Specifications |
| Market Size Value In 2023 | USD 808.4 Million |
| Revenue Forecast In 2031 | USD 2,130.5 Million |
| Growth Rate CAGR | CAGR of 10.3% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Product, By End-User |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape |
Alcon, Henan Universe IOL R&M Co., Ltd., Alievio Inc, Avisi Technologies LLC, Geuder AG, InnFocus Inc, iVeena Delivery Systems Inc, Merz Anteis SA, MicroOptx, Inc., OPKO Health Inc, Nova Eye Medical, New World Medical, Inc., Santen SA, Ivantis, Inc., Advanced Ophthalmic Innovations Pte Ltd, iSTAR Medical, Rheon Medical SA, and Johnson & Johnson Vision Care, Inc. AbbVie Inc. (Allergan), Glaukos Corporation, ASICO, LLC, Lumenis Be Ltd., Carl Zeiss Meditec AG,Katalyst Surgical, Aurolab, Novartis AG, Corza Ophthalmology, Abbott Medical Optics The Ziemer Ophthalmic System is among the other participants in the market. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
By Product-
By End-Users-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.